THE EFFECTS OF DANSHEN (SALVIA-MILTIORRHIZA) ON WARFARIN PHARMACODYNAMICS AND PHARMACOKINETICS OF WARFARIN ENANTIOMERS IN RATS

被引:88
作者
CHAN, K
LO, ACT
YEUNG, JHK
WOO, KS
机构
[1] CHINESE UNIV HONG KONG,DEPT PHARMACOL,HONG KONG,HONG KONG
[2] CHINESE UNIV HONG KONG,DEPT MED,HONG KONG,HONG KONG
关键词
D O I
10.1111/j.2042-7158.1995.tb05819.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of Danshen (Salvia miltiorrhiza), a popular traditional Chinese medicinal herb on the pharmacokinetics and pharmacodynamics of R- and S-warfarin stereoisomers were studied in rats. After a single oral dose of racemic warfarin (2 mg kg(-1)), treatment with oral Danshen extract (5 g kg(-1) twice daily) for 3 days significantly altered the overall pharmacokinetics of both R- and S-warfarin and increased the plasma concentrations of both enantiomers over a period of 24 h and the prothrombin time over 2 days. At steady-slate levels of racemic warfarin (0.2 mg kg day(-1) for 5 days) the 3-day treatment of Danshen extract (5 g kg(-1), twice daily) not only prolonged the prothrombin time but also increased the steady-state plasma concentrations of R- and S-warfarin. The results indicate that Danshen extracts can increase the absorption rate constant, area under plasma concentration-time curves, maximum concentrations and elimination half-lives, but decreases the clearances and apparent volume of distribution of both R- and S-warfarin. The pharmacokinetic and pharmacodynamic interactions of warfarin during co-treatment with Danshen extract observed in this study indicate an explanation for the clinically observed incidents of exaggerated warfarin adverse effects when traditional Chinese medicinal herbs or herbal products such as Danshen and Danggui (observed in a previous study) were co-administered.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 17 条
[1]   ENANTIOSELECTIVE STRUCTURE-PHARMACOKINETIC RELATIONSHIPS OF RING SUBSTITUTED WARFARIN ANALOGS IN THE RAT [J].
BAARS, LGM ;
SCHEPERS, MT ;
HERMANS, JJR ;
DAHLMANS, HJJ ;
THIJSSEN, HHW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (12) :861-866
[2]   PHENYLBUTAZONE-WARFARIN INTERACTION IN MAN - FURTHER STEREOCHEMICAL AND METABOLIC CONSIDERATIONS [J].
BANFIELD, C ;
OREILLY, R ;
CHAN, E ;
ROWLAND, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) :669-675
[3]  
BRECKENRIDGE A, 1973, BIOL EFFECTS DRUGS R, P145
[4]   ISOLATION AND DETERMINATION OF NEOSTIGMINE, PYRIDOSTIGMINE AND THEIR METABOLITES IN HUMAN BIOLOGICAL-FLUIDS [J].
CHAN, K ;
DEHGHAN, A .
JOURNAL OF PHARMACOLOGICAL METHODS, 1978, 1 (04) :311-320
[5]  
CHAN K, 1988, METHOD FIND EXP CLIN, V10, P699
[6]  
CHEN KJ, 1981, AM J CLIN MED, V9, P191
[7]  
Chen WZ, 1979, ACTA PHARMACOL SINIC, V14, P277
[8]   SIMULTANEOUS DETERMINATION OF BUFADIENOLIDES IN THE TRADITIONAL CHINESE MEDICINE PREPARATION, LIU-SHEN-WAN, BY LIQUID-CHROMATOGRAPHY [J].
HONG, Z ;
CHAN, K ;
YEUNG, HW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (12) :1023-1026
[9]   STUDIES ON CARDIOVASCULAR ACTIONS OF SALVIA-MILTIORRHIZA [J].
LEI, XL ;
CHIOU, GCY .
AMERICAN JOURNAL OF CHINESE MEDICINE, 1986, 14 (1-2) :26-32
[10]   WARFARIN - STEREOCHEMICAL ASPECTS OF ITS METABOLISM AND INTERACTION WITH PHENYLBUTAZONE [J].
LEWIS, RJ ;
TRAGER, WF ;
CHAN, KK ;
BRECKENRIDGE, A ;
ORME, M ;
ROLAND, M ;
SCHARY, W .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (06) :1607-1617